Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about LEXX
Recent news which mentions LEXX
< Previous
1
2
3
4
Next >
Lexaria Bioscience (NASDAQ: LEXX) Announces Positive Results From Hypertension Study
April 18, 2022
Tickers
LEXX
Tags
Benzinga
InvestorBrandNetwork
Biotech
From
Benzinga
51 Biggest Movers From Thursday
April 18, 2022
Tickers
AIRG
AMST
APCX
AREB
Tags
ARTL
Penny Stocks
MXC
From
Benzinga
Why Is Lexaria Bioscience (LEXX) Stock Up Today?
April 14, 2022
Tickers
LEXX
Tags
NASDAQ:LEXX
Market News
Today's Market
From
InvestorPlace
12 Health Care Stocks Moving In Thursday's Intraday Session
April 14, 2022
Tickers
BFRI
CLRB
HSTO
ISO
Tags
PYXS
PTGX
CLRB
From
Benzinga
Why Lexaria Shares Are Rising Today
April 14, 2022
Tickers
LEXX
Tags
Biotech
Benzinga
why it's moving
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Issues Update On Human Nicotine Study
April 13, 2022
Tickers
LEXX
LEXXW
Tags
Market News
Penny Stocks
General
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Begins Nicotine Formulation Creation, Evaluation Program
April 12, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Benzinga
From
Benzinga
Lexaria Aims To Demonstrate DehydraTECH's Performance In Epilepsy Research
April 11, 2022
Tickers
LEXX
Tags
Markets
LEXX
Partner Content
From
Benzinga
Lexaria Bioscience's 24th Patent Sets Stage For Market Opportunities In Australia
March 31, 2022
Tickers
LEXX
Tags
Benzinga
Biotech
InvestorBrandNetwork
From
Benzinga
Lexaria Bioscience Optimistic About Upcoming Hypertension Study
March 28, 2022
Tickers
LEXX
Tags
Partner Content
LEXX
Benzinga
From
Benzinga
Lexaria's IP Portfolio Grows Following Receipt Of 24th Granted Patent
March 22, 2022
Tickers
LEXX
Tags
Penny Stocks
Market News
General
From
Benzinga
Lexaria Bioscience Commences DehydraTECH-CBD Epilepsy Research Program
March 16, 2022
Tickers
LEXX
LEXXW
Tags
LEXX
Partner Content
LEXXW
From
Benzinga
Lexaria Bioscience Receives Award For Oral Nicotine Compound Patent
March 09, 2022
Tickers
LEXX
Tags
General
Penny Stocks
Market News
From
Benzinga
Studies Advance Lexaria Bioscience's Tech For Improving Pharmaceutical Drugs
March 07, 2022
Tickers
LEXX
Tags
Partner Content
LEXX
Benzinga
From
Benzinga
Lexaria's DehydraTECH(TM) Demonstrates Faster Delivery Of Sildenafil
March 04, 2022
Tickers
LEXX
TM
Tags
InvestorBrandNetwork
Biotech
Benzinga
From
Benzinga
Lexaria Bioscience Optimistic Of Positive Study Results
February 28, 2022
Tickers
LEXX
Tags
LEXX
Partner Content
Markets
From
Benzinga
Lexaria Optimistic About Expanded DehydraTECH Investigations
February 23, 2022
Tickers
LEXX
Tags
Market News
Penny Stocks
General
From
Benzinga
Lexaria World Leader Through DehydraTECH(TM) – Its Pioneering Drug Delivery Tech
February 22, 2022
Tickers
LEXX
TM
Tags
Penny Stocks
Market News
Investor Brand Network
From
Benzinga
Following Sildenafil Study, Lexaria Announces Plans For More Studies In 2022
February 17, 2022
Tickers
LEXX
Tags
General
Penny Stocks
Market News
From
Benzinga
Lexaria's DehydraTECH(TM) To Be Evaluated As Treatment For Multiple Conditions
February 14, 2022
Tickers
LEXX
TM
Tags
Market News
Penny Stocks
General
From
Benzinga
Lexaria Technology Shows Promise In Improving Performance Of ED Drugs
February 11, 2022
Tickers
LEXX
Tags
General
Market News
Penny Stocks
From
Benzinga
Lexaria CEO Summarizes 2021 Milestones in Letter to Shareholders
February 09, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Benzinga
From
Benzinga
Lexaria Bioscience Announces Significant Findings From Sildenafil Animal Study
February 03, 2022
Tickers
LEXX
Tags
General
News
Market News
From
Benzinga
Lexaria CEO Offers A Glimpse Into Company's Unique Tech On EDGE Podcast
February 01, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Benzinga
From
Benzinga
Lexaria Emphasizes Oral Cannabinoid Benefits Following SARS-CoV-2 Study
January 28, 2022
Tickers
LEXX
Tags
Market News
Penny Stocks
Cannabis
From
Benzinga
Lexaria Bioscience Marks Great Start to its 2022 R&D Programs
January 21, 2022
Tickers
LEXX
Tags
Biotech
InvestorBrandNetwork
Benzinga
From
Benzinga
Lexaria Bioscience Comments on Study Examining Cannabinoids and SARS-CoV-2
January 19, 2022
Tickers
LEXX
Tags
Cannabis
General
Penny Stocks
From
Benzinga
Lexaria Bioscience Leveraging DehydraTECH(TM) for More Effective Oral Medicine
January 18, 2022
Tickers
LEXX
TM
Tags
Penny Stocks
Market News
General
From
Benzinga
Lexaria Bioscience Celebrates Productive Year for Blood Pressure Drug Solution
January 12, 2022
Tickers
LEXX
Tags
General
Cannabis
Market News
From
Benzinga
Lexaria Bioscience (NASDAQ: LEXX) Receives Independent Review Board Approval for Human Study
January 11, 2022
Tickers
LEXX
Tags
LEXX
Partner Content
Benzinga
From
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.